TC
AMED

TFS Capital’s Amedisys AMED Stock Holding History

TFS Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-26,364
Closed -$1.27M – 951
2016
Q1 		$1.27M Buy
+26,364
New +$1.02M 0.18% 185
2015
Q4 		– Sell
-54,923
Closed -$2.08M – 741
2015
Q3 		$2.08M Buy
54,923
+4,552
+9% +$192K 0.2% 147
2015
Q2 		$2M Buy
+50,371
New +$1.57M 0.2% 143
2015
Q1 		– Sell
-32,048
Closed -$941K – 942
2014
Q4 		$941K Buy
+32,048
New +$791K 0.09% 374
2014
Q2 		– Sell
-12,373
Closed -$184K – 1108
2014
Q1 		$184K Sell
12,373
-211,473
-94% -$3.25M 0.01% 1210
2013
Q4 		$3.27M Sell
223,846
-134,236
-37% -$2.16M 0.15% 185
2013
Q3 		$6.16M Buy
358,082
+295,634
+473% +$4.39M 0.28% 70
2013
Q2 		$725K Buy
+62,448
New +$715K 0.03% 750

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

TFS Capital's AMED Position: Q2 2016 in Review

TFS Capital sold out of Amedisys (AMED) in Q2 2016, closing a stake of 26,364 shares — an estimated $1.27M sold.

TFS Capital first reported a position in AMED in Q2 2013 and held it in 8 quarters. The position peaked at $6.16M in Q3 2013. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

  • TFS Capital reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
  • TFS Capital sold 26,364 Amedisys shares in Q2 2016, an estimated $1.27M.
  • TFS Capital first reported a position in Amedisys in Q2 2013 and held it in 8 quarters.
  • TFS Capital's Amedisys position peaked at $6.16M in Q3 2013.
  • 168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.